Objective-Emerging evidence suggests that neuronal guidance cues, typically expressed during development, are involved in both physiological and pathological immune responses. We hypothesized that endothelial expression of such guidance cues may regulate leukocyte trafficking into the vascular wall during atherogenesis. Approach and Results-We demonstrate that members of the netrin, semaphorin, and ephrin family of guidance molecules are differentially regulated under conditions that promote or protect from atherosclerosis. Netrin-1 and semaphorin3A are expressed by coronary artery endothelial cells and potently inhibit chemokine-directed migration of human monocytes. Endothelial expression of these negative guidance cues is downregulated by proatherogenic factors, including oscillatory shear stress and proinflammatory cytokines associated with monocyte entry into the vessel wall. Furthermore, we show using intravital microscopy that inhibition of netrin-1 or semaphorin3A using blocking peptides increases leukocyte adhesion to the endothelium. Unlike netrin-1 and semaphorin3A, the guidance cue ephrinB2 is upregulated under proatherosclerotic flow conditions and functions as a chemoattractant, increasing leukocyte migration in the absence of additional chemokines. 
A therosclerosis is a chronic inflammatory disease of the large arteries, in which monocyte recruitment into the vessel wall plays an essential role in both the initiation and progression of disease. Atherosclerotic plaques form predominantly at sites of disturbed laminar flow, notably, arterial branch points and bifurcations, and are initiated by the subendothelial accumulation of apolipoprotein B-containing lipoproteins. 1, 2 The key early inflammatory response to these atherogenic lipoproteins is activation of overlying endothelial cells in a manner that leads to recruitment of blood-borne monocytes. 3 Research in the last decades has provided a rich description of the molecules involved in the recruitment of leukocytes into the artery wall, and highlighted the importance of the coordinated action of chemokines, integrins, and other adhesion molecules in directing this pathological process. 4 The chemoattractant and adhesive forces that recruit leukocytes to the vessel wall have been well studied in this context. 5 However, our understanding of other aspects of immune cell migration remains incomplete, particularly the mechanisms by which these cells are excluded from the artery in the absence of inflammation. In addition to the well-known positive migration cues that promote atherosclerotic plaque formation, it is reasonable to assume that chemorepulsive forces, or negative guidance cues, also exist to inhibit leukocyte-endothelial interactions under homeostatic conditions that may become dysregulated during disease.
The integration of chemoattractive and chemorepulsive signals is essential for controlling neuronal migration during development, and this paradigm is evolutionarily conserved from Caenorhabditis elegans to mammals. 6 Netrins, slits, semaphorins, and ephrins compose the 4 major families of conserved neuronal guidance cues that control neuronal migration and vascular patterning through a complex interplay of signals. However, accumulating evidence points to additional functions for these guidance molecules in regulating cell migration outside of the nervous system, including roles in the physiological and pathological regulation of the immune response. [7] [8] [9] Such studies have shown that members of the netrin, slit, semaphorin, and ephrin families of guidance cues can regulate immune cell activation or differentiation, and have both chemoattractive and chemorepulsive effects on leukocyte migration. [9] [10] [11] [12] For example, recent work from our group identified netrin-1 as a leukocyte guidance cue expressed by the endothelium, where its expression was modulated during acute inflammation because of Staphylococcus aureus infection. 11 In this model, netrin-1 was found to be expressed on the luminal surface of lung endothelial cells, where it acted to block the migration of monocytes to such bacterial factors as the N-formylated peptide N-formylmethionine-leucine-phenylalanine, suggesting that it may play a role in endothelial barrier function. At the onset of S. aureus infection or on treatment with tumor necrosis factor-α (TNF-α) in vitro, endothelial expression of netrin-1 was rapidly downregulated consistent with a lowering of this barrier to leukocyte infiltration of the tissues.
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Given the emerging roles for neuronal guidance cues in regulating inflammation, we hypothesized that these molecules may also have roles in early atherosclerosis, when, as alluded to above, endothelial dysfunction attributable to injury or lipoprotein retention precedes the development of atherosclerotic plaques. To perform a systematic evaluation of the 4 major classes of evolutionarily conserved neuronal guidance molecules, we used a microarray approach using RNA samples harvested from atherosclerosis-prone and -resistant aortic sites in a mouse model of early atherogenesis. We identified key members of the netrin, semaphorin, and ephrin families that are regulated in the initial stages of plaque formation, and confirmed these changes in arterial endothelial cells exposed to atherogenic factors in vitro. Notably, we identified guidance cues that both block (netrin-1 and semaphorin3A) or promote (ephrinB2) monocyte migration, and showed that their expression by endothelium is concurrently regulated by proatherosclerotic conditions in a manner that would facilitate leukocyte recruitment. Furthermore, using intravital microscopy, we demonstrated that blocking peptides targeting these molecules alters leukocyte adhesion to the endothelium in vivo, as would have been predicted by the array and in vitro results. Together, these data suggest an emerging paradigm for the coordination of leukocyte-endothelial interactions in vessel wall homeostasis by neuroimmune guidance cues.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Neuronal Guidance Molecules Are Differentially Regulated by Flow
It is well established that atherosclerotic lesions develop in areas of branching or high curvature that are associated with oscillatory or turbulent flow, so-called atheroprone regions. 13 We therefore investigated the expression of neuronal guidance molecules in 2 different regions of the vessel wall: (1) the inner curvature (atheroprone region) and (2) the outer curvature (atheroprotected or homeostatic region) of the aortic arch ( Figure  1A ). We placed Ldlr -/-mice on a Western diet for 2 weeks to model conditions for the early initiation of atherosclerosis, and isolated the inner and outer curvature from their aortic arches. Using custom mRNA arrays that covered all 4 families of neuronal guidance molecules, we compared the expression profile between these 2 vascular sites. In the aortic arch, we found that 31 of the 36 neuronal guidance molecules we profiled were expressed ( Figure 1B and 1C) . Comparing the expression of neuronal guidance molecules from the inner curvature relative to the outer curvature, we found that 10 were >25% downregulated in the inner compared with the outer curvature, and only 2 were >25% upregulated ( Figure 1C ). From these, we selected candidate molecules from the netrin, semaphorin, slit, and ephrin families and confirmed the array findings by independent quantitative real-time PCR ( Figure 1D ). Expression of netrin-1 (Ntn1), which we previously showed can limit the migration of monocytes, granulocytes, and lymphocytes, 11 was reduced by 48% in the inner curvature (atheroprone) compared with the outer curvature. Like Ntn1, another reported repulsive cue of the semaphorin family, semaphorin3A (Sema3a), was downregulated in the inner curvature compared with the outer curvature (-53%), consistent with roles in endothelial barrier function for these 2 guidance molecules. From the slit family, Slit1 was not detectable, whereas Slit2 was expressed at very low levels. However, Slit3 was confirmed to be expressed at similar levels between the inner and outer curvature. From the ephrin family, the ephrinB2 gene (Efnb2) was selected for validation, as ephrinB2 has been demonstrated to be expressed in vascular endothelial cells and may be sufficient to initiate monocyte-endothelial interactions.
12,14 However, we did not detect differential expression of Efnb2 mRNA between the inner curvature and outer curvature of the aorta ( Figure 1D ).
To directly investigate whether it was the endothelial cells of the aorta that contributed to the observed differences in Ntn1, Sema3a, and Efnb2 gene expression, and to extend those differences to the protein level, we performed immunostaining of longitudinal sections of the aortic arch of the Ldlr -/-mice fed a Western diet for 2 weeks. At this time point, changes in endothelial cell morphology are observed in the disturbed flow regions of the lesser curvature of the aorta, before the subendothelial accumulation of monocytes. 15 Netrin-1 immunostaining was detected in endothelial cells (positive for CD31) of the outer curvature, but was highly downregulated on endothelial cells of the inner curvature of the aortic arch ( Figure 2) . Similarly, semaphorin3A was expressed by endothelial cells in the atheroprotected outer curvature, whereas there was little to no semaphorin3A expression by endothelial cells of the inner aortic curvature. In contrast, endothelial cells of the inner aortic curvature expressed ephrinB2; however, staining for ephrinB2 was not detected in the atheroprotected outer curvature.
Endothelial Expression of Netrin-1, Semaphorin3A, and EphrinB2 Are Regulated by Proatherosclerotic Conditions In Vitro
Given the difference in netrin-1, semaphorin3A, and ephrinB2 mRNA, and protein levels in atheroprotected versus atheroprone regions of the aorta, we postulated that hemodynamic proatherosclerotic forces regulate the expression of these guidance cues on endothelial cells. We therefore seeded human coronary artery endothelial cells (HCAECs) onto fibronectincoated gas-permeable laboratory tubes and exposed them to arterial (atheroprotective), oscillatory (atheroprone) flow, or no flow (static) for 6 hours. As a positive control, we measured endothelial nitric oxide (Nos3), an atheroprotective factor known to be expressed under arterial laminar flow conditions, and found that its mRNA abundance was upregulated 3-fold compared with static control but was not significantly changed by oscillatory flow conditions compared with static control ( Figure 3A) . Similarly, Ntn1 mRNA was almost 5-fold upregulated by arterial flow, but unchanged in oscillatory flow conditions when compared with static control ( Figure 3A) . A different pattern emerged for Sema3a; expression of this gene was unchanged between static and arterial flow conditions, however it was highly downregulated by oscillatory flow (≈50%; Figure 3B ). Notably, Efnb2 gene expression was also regulated by oscillatory flow, but unlike Sema3a, it was significantly upregulated under these proatherosclerotic flow conditions (1.7-fold; Figure 3B ). Slit3 mRNA and protein were not affected by either atheroprotective or atheroprone flow conditions, and, therefore, was not investigated further ( Figure Fold change mRNA
Inner versus outer curvature ( Figure 4A ). In contrast, ephrinB2, which we found to be induced by oscillatory flow conditions, was not affected by atherosclerotic cytokines/chemokines ( Figure 4A ). Similar effects on Ntn1 and Sema3a mRNA were seen with other classical proatherogenic activators of the endothelium, such as IL-1β and TNF-α, as well as with bacterial lipopolysaccharide ( Figure 4B ). Notably, these proinflammatory stimuli increased Efnb2 mRNA in HCAEC ( Figure 4B ). To ascertain whether these changes were reflected at the protein level, we treated HCAECs with MCP-1 or TNF-α for 24 hours, and performed Western blotting for netrin-1, semaphorin3A, and ephrinB2. Expression of netrin-1 and semaphorin3A by HCAECs was decreased after treatment with MCP-1 and TNF-α, whereas ephrinB2 was increased under similar conditions ( Figure 4C ).
Netrin-1, Semaphorin3A, and EphrinB2 Regulate Leukocyte Migration
Because we observed lower expression of netrin-1 and semaphorin3A in regions of the aorta subject to proatherosclerotic/ oscillatory flow and in endothelial cells exposed to oscillatory flow conditions or proatherosclerotic cytokines, we hypothesized that endothelial expression of netrin-1 and semaphorin3A may act as a barrier to prevent monocyte migration into the arterial intima under basal conditions. To test this hypothesis, we investigated the effects of netrin-1 and semaphorin3A on monocyte migration to 2 chemokines implicated in monocyte recruitment during early atherogenesis; FKN (CX3CL1) and MCP-1 (CCL2). Cultured THP-1 monocytes or freshly isolated human peripheral blood mononuclear cells were used in modified Boyden chamber assays to examine monocyte migration to FKN or MCP-1 by adding recombinant netrin-1 to the lower chamber in the absence or presence of chemoattractants. As we previously reported, 11 recombinant netrin-1 did not alter monocyte migration in the absence of chemokine (data not shown). However, addition of recombinant netrin-1 inhibited peripheral blood mononuclear cell migration to FKN and MCP-1 by up to 50% ( Figure 5A and 5B). This inhibitory effect of netrin-1 was reversed by preincubation of peripheral blood mononuclear cells with an antibody that binds to the extracellular domain of Unc5b, a receptor for netrin-1 expressed by monocytes 11 ( Figure 5C ). Similarly, when semaphorin3A was added in combination with FKN or MCP-1, it was found to be a potent inhibitor of peripheral blood mononuclear cell chemotaxis to both FKN ( Figure  5D ) and MCP-1 ( Figure 5E ). In dose-response experiments, semaphorin3A-dependent effects on migration produces a bell-shaped curve (also typically seen with chemokines), with 60% to 90% inhibition observed at 250 ng/mL and reduced effects observed at the highest doses (1000 ng/mL; Figure 5D and E).
It has been previously demonstrated that class III secreted semaphorins can signal through neuropilins and plexins to mediate their effects on target cells. 16, 17 We therefore investigated whether neuropilin-1 was required for semaphorin3A-mediated inhibition of monocyte chemotaxis. THP-1 monocytes were preincubated with a blocking antibody to neuropilin-1 or an IgG isotype control antibody. Preincubation with the control antibody did not restore monocyte chemotaxis to MCP-1 ( Figure 5F ). However, preincubation with the neuropilin-1-blocking antibody restored the ability of THP-1 monocytes to respond to MCP-1 ( Figure 5F ).
In contrast to netrin-1 and semaphorin3A, ephrinB2 expression was observed to be upregulated in endothelial cells exposed to oscillatory flow conditions. Thus, we hypothesized that the upregulation of ephrinB2 may act to recruit monocytes into the arterial intima. To test this hypothesis, we examined the ability of ephrinB2 to act as a monocyte chemoattractant. Indeed, we found that ephrinB2 was a potent monocyte chemoattractant when added to the lower chamber of Boyden migration assays ( Figure 5G ). Migration was induced in a dose-dependent manner, with maximal chemotaxis observed at 250 ng/mL of ephrinB2. When ephrinB2 was added with FKN or MCP-1 to the lower well, chemotaxis was similar to that seen with ephrinB2 alone (data not shown), indicating that the effects on chemotaxis were not additive.
Netrin-1 and Semaphorin3A Inhibit Leukocyte Adhesion
We next investigated whether netrin-1 and semaphorin3A could alter leukocyte adhesion. Treatment with netrin-1 or semaphorin3A, both at 250 ng/mL, reduced the adhesion of RAW264.7 cells to surfaces coated with BSA by 50% to 60% ( Figure 6A ). As netrin-1 and semaphorin3A inhibit both leukocyte migration and adhesion in vitro, we next determined whether enhancing or blocking these 2 negative guidance molecules would alter leukocyte-endothelial dynamics. We find that netrin-1 and semaphorin3A actively inhibit THP-1 monocyte binding to HCAEC treated with TNF-α ( Figure 6B and 6C) or lipopolysaccharide ( Figure IB in the online-only Data Supplement). Conversely, blocking peptides to netrin-1 and semaphorin3A increased THP-1 adhesion to quiescent HCAEC ( Figure 6D) . Hence, the expression of netrin and semaphorin3A by the endothelium would be expected to actively prevent leukocyte arrest and tissue entry.
To examine this we used intravital microscopy, a technique that allows the observation of leukocyte-endothelial cell interactions in vivo. 18 Similar to areas of disturbed blood flow in the conduit artery, the venous system is exposed to low shear stress ranging from 1 to 6 dynes/cm of the cremaster vein has proven to be a useful in vivo model for assessing leukocyte-endothelial cell interactions relevant to atherosclerosis. [19] [20] [21] Intravenous infusion of netrin-1-or semaphorin3A-blocking peptides to C57BL/6J mice did not alter leukocyte rolling but significantly increased leukocyte adhesion to the endothelium compared with control peptides (Figure 7A and 7B) . The number of leukocytes adherent to the endothelium increased approximately 2-fold after the addition of netrin-1-or semaphorin3A-blocking peptides ( Figure 7B ), further supporting our hypothesis that these guidance cues act to impair this earliest interaction with endothelial cells in vivo.
Discussion
The pioneering studies from the Gimbrone laboratory showed that the properties of atheroprone and susceptible regions of the aorta varied in a number of significant ways that could be attributed to the different flow characteristics at specific sites. 13 For example, endothelial cells in the lesser (inner) curvature of the aortic arch or at branch points, where the laminar flow tended to be lower, were relatively activated. These observations were subsequently extended by a number of investigators to show that before there was evidence of monocyte infiltration, a host of molecules, such as P-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and endothelial nitric oxide, were already adversely affected in the susceptible areas. 3, 13 Based on the results of the present studies, we can now add certain neuronal guidance molecules as early-disease stage, atheroregulatory, factors that also operate at the level of the endothelium.
Based on the microarray gene expression results (Figure 1) , we focused on netrin-1 and semaphorin3A, because of their decreased expression in the atheroprone, lesser curvature in the aortae of prelesional, but diet-stimulated, Ldlr -/-mice. We also included analyses of eprinB2 and slit3 as members of their respective classes of neuronal guidance molecules. In our previously published studies, we reported that netrin-1 inhibits monocyte migration in vitro in response to bacterial N-formylmethionine-leucine-phenylalanine. 11 In that same study, we found that netrin-1 was expressed in the vascular endothelium of the lung, as well as in human umbilical vein endothelial cells, and that its expression was rapidly downregulated during acute inflammation. Based on these findings, we hypothesized that the higher expression of netrin-1 in the endothelium of the atheroresistant greater curvature reflected an important and novel mechanism by which leukocyte interactions with endothelial cells are limited in homeostatic conditions. Furthermore, we considered that there could also be regulation of leukocyte entry into susceptible arterial regions by other neuronal guidance molecules, given some overlap in properties among the family members.
Importantly, we found that the expression of netrin-1 and semaphorin3A was increased under conditions that recapitulated the steady flow found in healthy arterial segments relative to the oscillatory pattern found at arterial regions prone to development of atherosclerotic plaques, as would be expected if these molecules were atheroprotective at the endothelial cell level. Endothelial expression of netrin-1 and semaphorin3A was also decreased by treatment with proinflammatory cytokines or chemokines implicated in leukocyte recruitment to atheroprone regions. We had previously demonstrated that most leukocyte subclasses, including monocytes/macrophages and neutrophils, express the chemorepulsive receptor for netrin1, Unc5b. 11, 22 This suggests that when circulating monocytes encounter an endothelial cell expressing relatively more netrin-1, a barrier mechanism would be triggered either because secreted netrin-1 inhibited monocyte chemotaxis by creating a diffusible netrin-1 gradient across endothelial cell layers (similar to that created by endothelial cell-secreted MCP-1), or through presentation of netrin-1 on the surface of endothelial cells. In this regard, there is evidence of netrin-1 binding to α6β4 and α3β1 integrins on pancreatic epithelial cells, 23 and this is one mechanism by which netrin-1 could be presented on arterial endothelial cells.
Consistent with either scenario, our results show that (1) netrin-1 inhibits leukocyte migration to the proatherogenic chemokines, MCP-1 and FKN, in vitro, in a manner that involves the Unc5b receptor; (2) netrin-1 inhibits monocyte binding to endothelial cells; and (3) peptides that block netrin-1 increase leukocyte adhesion to endothelium in vitro. In addition to supporting an atheroprotective role for netrin-1 at the endothelial level, the current study also suggests a similar role for semaphorin3A. For example, semaphorin3A inhibited monocyte migration to MCP-1 in vitro in a process dependent on its receptor neuropilin, and a semaphorin3A-blocking peptide also reduced leukocyte adhesion in vitro. Notably, using intravital microscopy of the cremaster vein, we show that administration of netrin-1 and semaphorin3A-blocking peptides similarly increase leukocyte adhesion in vivo.
Turning to ephrinB2, in contrast to netrin-1 and semaphorin 3A, it was upregulated in HCAECs in vitro by proatherogenic (oscillatory) flow (Figure 3 ), and at the protein level, it was more highly expressed in the inner curvature endothelium ( Figure 2 ). Another contrast was that it acted to stimulate leukocyte recruitment. These findings are supported by Goettsch et al, 24 who found that ephrinB2 expression was downregulated by arterial, but not venous, laminar shear stress in HUVECs, 24 suggesting that this downregulation may keep endothelial cells in a nonactivated state. Other supporting data for a role of ephrinB2 in vivo are contained in a report that showed that monocytes express EphB2, one of the possible receptors for ephrinB2, and that the expression of EphB2 in monocytes is increased on their adhesion. 14 In agreement with the present results, in that report, there was also greater expression of ephrinB2 in the endothelium of the lesser curvature, which correlated with an increased abundance of macrophages in the underlying neointima. 14 Although we have shown that there is concurrent regulation of netrin-1, semaphorin3A, and ephrinB2 in the endothelium, resulting in concerted atheroprotective effects, whether this represents a common coordinating regulatory mechanisms or a more complex process remains to be determined. In contrast to Ntn1 and Sema3a, we did not detect a difference in EfnB2 mRNA expression in the atheroprone and atheroresistant sites of the aorta, which implies that a combination of transcriptional and posttranscriptional mechanisms may regulate the expression of these factors. Similarly, whereas TNF-α treatment of HCAECs markedly downregulated Sema3a mRNA, as well as netrin-1 and semaphorin3A protein levels, this cytokine increased Ntn1 mRNA in vitro. There are scant data about the regulation of endothelial expression for any of the factors we studied. There is some evidence for netrin-1 that NF-κB and hypoxia-inducible factor-1α may be involved in its transcriptional upregulation, 25, 26 but on the surface, this would be counter to the present results in that (1) treatment with lipopolysaccharide or TNF-α (activators of NF-κB) or MCP-1 (a classic target of NF-κB) was associated with decreased netrin-1 expression ( Figure 4) ; and (2) in areas of disrupted laminar flow (as in the lesser curvature of the aortic arch), hypoxia-inducible factor-1α is induced independent of hypoxia. Thus, although the phenomenon of intersecting protective changes in the 3 guidance molecules is clear, a dissection of the underlying regulatory mechanisms awaits detailed analyses beyond the scope of the present report. Our data suggest that netrin-1 and semaphorin3A may reduce leukocyte migration and recruitment to atherosclerotic plaque by inhibiting firm adhesion to the vessel wall. In vivo, leukocyte recruitment to inflamed sites is mediated by a combination of adhesion and signaling molecules. Selectins, expressed at inflamed sites, slow leukocytes and initiate rolling; next, chemokine signaling to leukocytes activates integrins to mediate firm adhesion and subsequent extravasation. Our observations that netrin-1 and semaphorin3A inhibit the initiation of firm adhesion are consistent with known roles for neuronal guidance molecules. For example, semaphorin3A inhibits the activation and adhesive function of β1 and β3 integrins in endothelial cells, 27 and similar effects might be expected to regulate activity of β2 integrins on leukocytes, which are primarily responsible for firm adhesion of leukocytes to the vessel wall. Netrin-1 has also been shown to bind to integrins (α3 and α6) and to activate integrin ligand binding through focal adhesion kinase and small GTPases. 23 In summary, our data support a model (Figure 7 ) in which the inhibitory guidance molecules netrin-1 and semaphorin3A are more highly expressed by endothelial cells in atheroresistant aortic regions, where they help to maintain tissue homeostasis by preventing leukocyte influx. In atheroprone regions, however, they become downregulated by disturbed laminar flow and local inflammation, which lowers the endothelial barrier to leukocyte entry. Consistent with this model, systemic delivery of netrin-1 to Ldlr -/-mice using adenovirus-associated virus reduced atherosclerosis, 28 presumably by increasing its expression on endothelial cells. Adding to the increased predilection for leukocyte recruitment in the prone regions is the upregulation of another guidance molecule, eprinB2, which increases monocyte migration in vitro. In addition to these guidance cues, which we selected for in-depth study, our microarray profiling data suggest that additional family members, including Ntng2, Sema3g, Sema4d, and Sema7a, may also be relevant to atherosclerotic processes. During development, the various families of guidance molecules have been shown to have overlapping effects and to also coregulate each other positively or negatively. Further exploration of the expression of neuronal guidance molecules and their receptors under resting and inflammatory conditions, and their functional interactions, will likely identify new regulatory mechanisms and therapeutic targets in atherosclerosis and other inflammatory disorders.
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